Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

In the summer of 2017, Nina Jankowicz, a twenty-eight-year-old American, was working in Kyiv as a communications adviser to Ukraine’s foreign ministry as part of a yearlong Fulbright fellowship.

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.

Cathie Wood’s ARK ETF published their daily trades for Friday, December 19th, 2025, showcasing significant activity in several key stocks. Leading the trades was a substantial sale of 23,110 shares of ...

Haupt is a health and wellness editor at TIME. Andrew Brodhead Laura Carstensen's favorite lecture of the year is the one when she tells undergrads at Stanford University that—contrary to what they've ...

Einstein was born in 1879. He’d be 147 years old this year. He did so much for helping people understand how the world works. His exploration changed humanity and its search for meaning. Not everyone ...